
About Syndicate Life Sciences
Syndicate Life Sciences is a Healthcare company based in Hisar (India) founded in 2010. Pharmaceutical drug manufacturing and distribution in India, focusing on affordable health solutions. The company has 18 employees. Its Indian entity Syndicate Life Sciences Private Limited reported revenue of βΉ18.03 Cr. Syndicate Life Sciences offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Drugs and Pharmaceutical Distribution.
Company details
Syndicate Life Sciences is recognized as a trusted entity in the pharmaceutical sector, where a wide range of high-quality drugs, including tablets, capsules, syrup, dry syrup, powder, and injectables, is delivered at affordable prices across the country. The well-being of people is addressed through the provision of innovative and effective drugs that cater to various health needs. Operations are supported by manufacturing and business opportunities, ensuring accessibility and reliability in the market. This approach is evident in the companys commitment to quality and distribution efforts.
- Headquarters Hisar, India
- Employees 18
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website syndicatelife.com
- Social LinkedIn X Facebook
- Legal Name Syndicate Life Sciences Private Limited
- Date of Incorporation 15 Feb, 2010
- Jurisdiction Hisar, Haryana, India
- Annual Revenue₹18.03 Cr
FY 2026 · +12% YoY
- Net Profit₹14.1 Lakh
FY 2026 · 1% margin
- EBITDA₹63.4 Lakh
FY 2026 · 4% margin
- Employee Count18
Associated legal entities of Syndicate Life Sciences
Syndicate Life Sciences operates through Syndicate Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Syndicate Life Sciences Private Limited CIN U24233HR2010PTC040080 | Active | 15 Feb 2010 | Hisar, Haryana | ₹18.0 Cr | 2 | View details |
Products & Services of Syndicate Life Sciences
Syndicate Life Sciences offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are manufactured and supplied as part of a range of drugs for health purposes
Capsules are provided within the assortment of high-quality drugs for medical applications
Board of directors of Syndicate Life Sciences Private Limited (Syndicate Life Sciences)
Syndicate Life Sciences Private Limited is the primary company behind Syndicate Life Sciences. The board of Syndicate Life Sciences Private Limited currently have 2 directors; the longest-serving is Nitin Bhayana, appointed in 2010.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nitin Bhayana DIN 02898201 | Director | 15 Feb 2010 | 16 yrs 9 mo | Syndicate Life Sciences Private Limited |
| Sagar Uppal DIN 02883026 | Director | 15 Feb 2010 | 16 yrs 9 mo | Syndicate Life Sciences Private Limited |
Financials of Syndicate Life Sciences
Figures of Syndicate Life Sciences Private Limited, the primary company behind Syndicate Life Sciences, for FY 2026. Revenue was ₹18.03 Cr (+12% year on year). Net profit was ₹14.1 Lakh (1% margin). EBITDA was ₹63.4 Lakh (4% margin). Revenue has grown at a compounded annual rate of +17% over three years and +19% over five years.
- ₹18.03 CrRevenue · FY 2026 · +12% YoY
- ₹14.1 LakhNet profit · 1% margin
- ₹63.4 LakhEBITDA · 4% margin
- ₹22.9 LakhPaid-up capital
- +17%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Syndicate Life Sciences Private Limited are on its company page.
Detailed financial statements for Syndicate Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Syndicate Life Sciences
The website of Syndicate Life Sciences (syndicatelife.com) receives about 1.1K visits a month.
- Monthly visits1.1K
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Syndicate Life Sciences
Syndicate Life Sciences was founded in 2010.
Syndicate Life Sciences is headquartered in Hisar, India. It is registered at Hisar, Haryana, India.
Syndicate Life Sciences has 18 employees.
The primary company behind Syndicate Life Sciences, Syndicate Life Sciences Private Limited, reported revenue of βΉ18.03 Cr for FY 2026, up 12% year on year.
Syndicate Life Sciences is recognized as a trusted entity in the pharmaceutical sector, where a wide range of high-quality drugs, including tablets, capsules, syrup, dry syrup, powder, and injectables, is delivered at affordable prices across the country. The well-being of people is addressed through the provision of innovative and effective drugs that cater to various health needs. Operations are supported by manufacturing and business opportunities, ensuring accessibility and reliability in the market. This approach is evident in the companys commitment to quality and distribution efforts.
Syndicate Life Sciences offers Tablets and Capsules.
Syndicate Life Sciences operates through Syndicate Life Sciences Private Limited.
The legal entities of Syndicate Life Sciences currently have 2 directors, including Nitin Bhayana, Sagar Uppal.